Literature DB >> 17955026

Breaking the bonds: non-viral vectors become chemically dynamic.

Jon A Wolff1, David B Rozema.   

Abstract

The delivery of a variety of nucleic acids such as plasmid DNA (pDNA) and small interfering RNA (siRNA) to mammalian cells is both an important research tool and potential therapeutic approach. Synthetic vehicles (SVs) that include lipoplexes and polyplexes, are widely used for non-viral delivery. A promising method of improving the efficacy of this approach is to create SVs that are chemically dynamic, so that delivery is enabled by the cleavage of chemical bonds upon exposure to various physiological environments or external stimuli. An example of this approach is the use of masked endosomolytic agents (MEAs) that improve the release of nucleic acids from endosomes, a key step during transport. When the MEA enters the acidic environment of the endosome, a pH-labile bond is broken, releasing the agent';s endosomolytic capability. Another challenge has been to develop SVs that enable in vivo delivery. Recently, an MEA that was used within dynamic polyconjugates (DPCs) enabled the efficient delivery of siRNA into hepatocytes in vivo. The use of labile bonds to mask endosomolytic agents, provides a critical design feature, because it enables efficient in vivo delivery without sacrificing endosomolytic function for release into the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955026     DOI: 10.1038/sj.mt.6300326

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  45 in total

1.  Interaction of nucleic acids with the glycocalyx.

Authors:  Michael J Palte; Ronald T Raines
Journal:  J Am Chem Soc       Date:  2012-03-29       Impact factor: 15.419

Review 2.  Synthetic cell surface receptors for delivery of therapeutics and probes.

Authors:  David Hymel; Blake R Peterson
Journal:  Adv Drug Deliv Rev       Date:  2012-02-25       Impact factor: 15.470

3.  Addition of ascorbic acid to the extracellular environment activates lipoplexes of a ferrocenyl lipid and promotes cell transfection.

Authors:  Burcu S Aytar; John P E Muller; Sharon Golan; Shinichi Hata; Hiro Takahashi; Yukishige Kondo; Yeshayahu Talmon; Nicholas L Abbott; David M Lynn
Journal:  J Control Release       Date:  2011-09-22       Impact factor: 9.776

Review 4.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

5.  Advancing polymeric delivery systems amidst a nucleic acid therapy renaissance.

Authors:  Paul A Burke; Suzie H Pun; Theresa M Reineke
Journal:  ACS Macro Lett       Date:  2013-10-15       Impact factor: 6.903

Review 6.  Functional lipids and lipoplexes for improved gene delivery.

Authors:  Xiao-Xiang Zhang; Thomas J McIntosh; Mark W Grinstaff
Journal:  Biochimie       Date:  2011-05-20       Impact factor: 4.079

Review 7.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

8.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

Review 9.  Lipid-based nanotherapeutics for siRNA delivery.

Authors:  A Schroeder; C G Levins; C Cortez; R Langer; D G Anderson
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

Review 10.  Sequence-non-specific effects of RNA interference triggers and microRNA regulators.

Authors:  Marta Olejniczak; Paulina Galka; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.